TCL Archive Continuing Resolution Averts Shutdown; Locks in Sequestration Cuts for NIH, NCI March 22, 2013
TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive PRI, Fending Off More Giants, Reportedly wins New operations. Support contract at Frederick July 10, 1987
